Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

6.190 -0.290 (-4.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 823,923
Open 6.600
Bid (Size) 6.190 (10)
Ask (Size) 6.200 (19)
Prev. Close 6.480
Today's Range 6.115 - 6.669
52wk Range 1.990 - 7.790
Shares Outstanding 48,518,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Personalis, Inc.
Via Business Wire
Cramer Says Tesla Dominates While Ouster Is 'Too Speculative'
Jim Cramer advises against investing in Tempus AI due to its ongoing losses and suggests Pan American as a profitable alternative. Insmed is also considered speculative while the only viable option for... 
Via Benzinga
Topics Artificial Intelligence

Performance

YTD
-1.3%
-1.3%
1 Month
-0.6%
-0.6%
3 Month
+94.0%
+94.0%
6 Month
+29.5%
+29.5%
1 Year
+175.1%
+175.1%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Scheduled For May 6, 2025
Via Benzinga
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
What's going on in today's after hours session
Via Chartmill
Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients
From Personalis, Inc.
Via Business Wire
Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
From Personalis, Inc.
Via Business Wire
New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
From Personalis, Inc.
Via Business Wire
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
From Personalis, Inc.
Via Business Wire
Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference
From Personalis, Inc.
Via Business Wire
Analyst Expectations For Personalis's Future
Via Benzinga
Personalis Reports First Quarter 2025 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
From Personalis, Inc.
Via Business Wire
Personalis to Announce First Quarter 2025 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection
From Personalis, Inc.
Via Business Wire
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
Via Investor's Business Daily
What 5 Analyst Ratings Have To Say About Personalis
Via Benzinga
Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip
Via Benzinga
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
From Personalis, Inc.
Via Business Wire
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference
From Personalis, Inc.
Via Business Wire

Frequently Asked Questions

Is Personalis, Inc. - Common Stock publicly traded?
Yes, Personalis, Inc. - Common Stock is publicly traded.
What exchange does Personalis, Inc. - Common Stock trade on?
Personalis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Personalis, Inc. - Common Stock?
The ticker symbol for Personalis, Inc. - Common Stock is PSNL on the Nasdaq Stock Market
What is the current price of Personalis, Inc. - Common Stock?
The current price of Personalis, Inc. - Common Stock is 6.190
When was Personalis, Inc. - Common Stock last traded?
The last trade of Personalis, Inc. - Common Stock was at 07/18/25 04:00 PM ET
What is the market capitalization of Personalis, Inc. - Common Stock?
The market capitalization of Personalis, Inc. - Common Stock is 300.33M
How many shares of Personalis, Inc. - Common Stock are outstanding?
Personalis, Inc. - Common Stock has 300M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.